申请人:——
公开号:US20040102436A1
公开(公告)日:2004-05-27
The present invention provides a compound which is useful as a PGI
2
receptor agonist, and a pharmaceutical composition.
The present invention is directed to a pharmaceutical composition comprising a compound represented by the following formula [1]:
1
(R
1
and R
2
are the same or different and each represents optionally substituted aryl, Y represents N or CH, Z represents N or CH, A represents NH, NR
5
, O, S, or ethylene, R
5
represents alkyl, D represents alkylene or alkenylene, E represents phenylene or single bond, G represents O, S, or CH
2
, R
3
and R
4
are the same or different and each represents hydrogen or alkyl, Q represents carboxy, alkoxycarbonyl, tetrazolyl, carbamoyl, or N-(alkylsulfonyl)carbamoyl), or a pharmaceutically acceptable salt thereof as an active ingredient.
本发明提供了一种作为PGI2受体激动剂有用的化合物和制药组合物。本发明涉及一种制药组合物,其包括由以下式子[1]表示的化合物:1(其中R1和R2相同或不同,每个表示可选择取代的芳基,Y表示N或CH,Z表示N或CH,A表示NH、NR5、O、S或乙烯,R5表示烷基,D表示烷基或烯基,E表示苯基或单键,G表示O、S或CH2,R3和R4相同或不同,每个表示氢或烷基,Q表示羧基、烷氧羰基、四唑基、氨基甲酰基或N-(烷基磺酰)氨基甲酰基),或其药学上可接受的盐作为活性成分。